Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
For much of the 20th century, the pharmaceutical industry focused on chemicals and small molecules to inhibit/activate cellular processes and act as drugs.
GO Prime with only $1.49 now
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115